...
首页> 外文期刊>Experimental and therapeutic medicine >Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma
【24h】

Expression of c-myc and PCNA in Epstein-Barr virus-associated gastric carcinoma

机译:c-myc和PCNA在爱泼斯坦-巴尔病毒相关胃癌中的表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to detect the expression of proliferatng cell nuclear antigen (PCNA) and c-myc in Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) and EBV-negative gastric carcinoma (EBVnGC), as well as the expression of EBV-encoded proteins in EBVaGC and their effect on carcinogenesis and the development of gastric cancer. The PCNA and c-myc protein levels were assessed by immunohistochemistry in 13 EBVaGC and 45 EBVnGC specimens. The expression of related genes of EBV, including EB nuclear antigen (NA)-1 and EBNA2 genes, latent membrane protein 1 (LMP1) and early genes BARF1 and BHRF1 were tested by reverse transcription-polymerase chain reaction (RT-PCR) and southern blotting. The PCNA labeling index (LI) of EBVaGCs, EBVnG.Cs and the corresponding adjacent tissues of EBVaGCs were 49.3768 +/- 12.1832, 14.839 +/- 7.1847, 35.613 +/- 8.3831 and 24.2735 +/- 10.1332, respectively. The PCNA LI was significantly different between EBVaGC and EBVnGC of EBVaGC (t=4.686, P<0.01). The difference between EBVaGC and corresponding adjacent tissues of EBVaGC was also significant (t=8.805, P<0.01). The expression of c-myc protein was detected in 33 of 58 (55.39%) gastric carcinomas and in 21 of 58 (36.21%) adjacent tissues. There was a significant difference between the two groups (chi(2)=4.989, P<0.05). The expression of the c-myc protein was detected in 8 of 13 (61.54%) EBVaGCs and in 25 of 45 (55.56%) EBVnGCs. The difference between the two groups was not significant (chi(2)=0.147, P>0.05). EBNA1 mRNA was detected in all 13 EBVaGC cases, while EBNA2 and LMP1 mRNA was not detected in these cases. Of the 13 EBV-positive samples, 6 exhibited BARF1 transcripts and 2 exhibited BHRF1 transcripts. c-myc expression did not correlate with the presence of EBV in EBVaGC. EBV infection may induce PCNA expression. The lack of EBNA2 and LMP1 protein expression in EBVaGC suggests that EBNA2 and LMP1 do not correlate with cell apoptosis and c-myc expression. Early genes BARF1 and BHRF1 may play an important role in the development and progression of gastric carcinomas by immortalizing epithelial cells.
机译:这项研究的目的是检测增殖细胞核抗原(PCNA)和c-myc在与爱泼斯坦巴尔病毒(EBV)相关的胃癌(EBVaGC)和EBV阴性胃癌(EBVnGC)中的表达,以及EBVaGC中EBV编码蛋白的表达及其对胃癌发生和发展的影响。通过免疫组织化学在13份EBVaGC和45份EBVnGC标本中评估了PCNA和c-myc蛋白的水平。通过逆转录-聚合酶链反应(RT-PCR)和Southern blot检测了EBV相关基因的表达,包括EB核抗原(NA)-1和EBNA2基因,潜伏膜蛋白1(LMP1)以及早期基因BARF1和BHRF1。印迹。 EBVaGC,EBVnG.C和对应的EBVaGC相邻组织的PCNA标记指数(LI)分别为49.3768 +/- 12.1832、14.839 +/- 7.1847、35.613 +/- 8.3831和24.2735 +/- 10.1332。 EBVaGC的EBVaGC和EBVnGC之间的PCNA LI显着不同(t = 4.686,P <0.01)。 EBVaGC与相应的EBVaGC相邻组织之间的差异也很显着(t = 8.805,P <0.01)。在58例(55.39%)胃癌和58例相邻组织(36.21%)的胃癌中检测到c-myc蛋白的表达。两组之间有显着差异(chi(2)= 4.989,P <0.05)。在13个EBVaGC中有8个(61.54%)和45个(55.56%)EBVnGC中有25个检测到c-myc蛋白的表达。两组间差异无统计学意义(chi(2)= 0.147,P> 0.05)。在所有13例EBVaGC病例中均检测到EBNA1 mRNA,而在这些病例中未检出EBNA2和LMP1 mRNA。在13个EBV阳性样本中,有6个显示BARF1转录本,而2个显示BHRF1转录本。 c-myc表达与EBVaGC中EBV的存在无关。 EBV感染可能诱导PCNA表达。 EBVaGC中缺乏EBNA2和LMP1蛋白表达,这表明EBNA2和LMP1与细胞凋亡和c-myc表达无关。早期基因BARF1和BHRF1通过使上皮细胞永生化,可能在胃癌的发生和发展中发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号